Virtify launches on-line data disclosure solution

By Gareth Macdonald

- Last updated on GMT

Related tags: Life sciences companies, Regulation, Clinical trial

Virtify says the new online version of its Virtx CTRR system can help drugmakers comply with the increasingly complex disclosure rules that regulators worldwide apply to clinical trials, in an automated approach that saves time and money.

The software automates all workflow and data gathering in clinical trials, capturing the information in the format required by the appropriate regulator in an approach that, Virtify believes, reduces the time it takes to put submissions together.

A company spokesman told Outsourcing-pharma that increasing disclosure and transparency requirements from regulators worldwide had driven the development of the online version of Virtx clinical trial results and registry (CTRR) solution.

Regulatory bodies and international health organizations necessitate that all companies performing clinical trials provide increased transparency and disclosure of clinical trial procedures, results and, soon, adverse events.

Despite this, he continued, “many life sciences companies are scrambling to fully understand and comply with these requirements,” adding that “They are not sure how to ensure compliance from country to country and state to state.”

Non-compliance can have a significant financial impact on drugmakers in terms of launch delays and lost market opportunity, particularly the types of small and midsized companies for which Virtx CTRR was developed.

The system is updated in real-time when new rules are announced. The spokesman explained that: “Virtify tracks these evolving regulations and restrictions closely and is an active member in many of the standards bodies worldwide.

Data disclosure market

Traditionally, pharmaceutical firms have taken one of two approaches to the problem of trial disclosure and management. The first option is to license individual solutions for each reporting process required during the trial.

Although using dedicated software for each process can be effective, the lack of cross software integration can throw up a variety of non-trial related problems such as, for example, data formatting issues that could delay submission.

The second common approach taken to data disclosure is to use a non-specific content management system which, while undoubtedly effective in some applications, may lack the specific functionality required to manage some aspects of the trial process.

In contrast, Virtify believes the hybrid approach offered by Virtx CTRR is something different.

The Virtx platform is purpose built for life sciences companies and regulated content submissions. Virtify has then built specific functionality and solutions for each of the different regulatory processes life sciences companies have to manage​.”

Related news

Show more

Related products

show more

The Essential Clinical Development Resource Center

The Essential Clinical Development Resource Center

Data Management Solution Center | 05-Mar-2020 | Data Sheet

Clinical trials are becoming increasingly complex with oversight workloads increasing too. A recent survey based study conducted by Medidata in association...

Infographic:Transforming Data Capture & Management

Infographic:Transforming Data Capture & Management

Data Management Solution Center | 05-Mar-2020 | Infographic

Is your clinical study's data capture and management processes efficient? Medidata Rave Clinical Cloud is the only industry platform that creates...

Electronic Informed Consent and Global Regulation

Electronic Informed Consent and Global Regulation

Data Management Solution Center | 05-Mar-2020 | Technical / White Paper

Medidata is conducting an on-going study to understand global regulatory positions, adoption and variability regarding eConsent. The benefits of eConsent...

De-risk Go/No Go Product Development Decisions

De-risk Go/No Go Product Development Decisions

Data Management Solution Center | 05-Mar-2020 | Technical / White Paper

Learn how synthetic controls enable new insights for oncology clinical development and mitigates go/no-go decision risk. Synthetic control data can assist...

Related suppliers

Follow us


View more